In Depth
Moral Distress and workism in pharmacy
Is your work life starting to affect your overall health? Curtis Ruhnau believes it’s important to define just why many pharmacists may be struggling to deal with work/life issues …
Research Roundup
Debbie Rigby rounds up the latest in research news Placebos in clinical care: a suggestion beyond the evidence Placebos provide important treatment effects but are often driven by myths and …
Looking at the market
Is the pharmacy real estate market continuing to perform well after 18 months of the pandemic? Leading broker Natalie Sirianni provides her view The pharmacy market in Australia is complex …
Clinical Tips: Peyronie’s disease
Not many people talk about it, but Peyronie’s disease affects a good number of men, writes Brad Butt Peyronie’s disease occurs when plaques (segments of fibrotic or scar-like tissue) form …
Making a difference
Pharmacists can make a big difference to the lives of people with diabetes, says credentialled diabetes educator (CDE) Jayne Lehmann. “They can pick up a lot about a person from …
Insulin resistance insights revealed
Healthcare professionals can foster timely insulin initiation by supporting patients with realistic, accurate perceptions of diabetes and its treatment from day one. A recent study1 provides insights into some of …
Not so sweet
Guidelines are flawed and must be revised as type 2 diabetes is reversible, says the 2020 Australian of the Year. Dietary1 and clinical guidelines2 must change along with our love …
Cost of continuous glucose monitoring prohibitive for most
Findings released from one of the largest surveys of people with type 1 diabetes (T1D) reveals the cost of managing the condition is resulting in poor health outcomes, including depression. …
Fenofibrate finds fame
Diabetic retinopathy (DR) is the leading cause of preventable blindness of working-age adults in the world.1 In Australia it is one of the top five causes of irreversible blindness among …
Lockdown linked to rise in gestational diabetes
Melbourne lockdowns see gestational diabetes cases rise, while experts warn women are missing out on funded-education and support. COVID lockdowns could be behind an increase seen in the rate of …
100 years since the discovery of insulin: the roadmap to our next big breakthrough
It’s an exciting time for type 1 diabetes (T1D) research with several big breakthroughs poised to make a significant impact on the lives of people with the disease, writes Dr …
Diabetes Updates
‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …